文献速递湿疹皮炎与荨麻疹

儿童特应性皮炎疾病轨迹:更新与临床医生指南

Disease trajectories in childhood atopic dermatitis: an update and practitioner's guide.
PubMed 文献 · Br J Dermatol · 2019-05-15

本文综述近期队列研究,梳理儿童特应性皮炎(AD)的疾病轨迹与进展风险因素,发现早发、家族特应性史、AD严重度、丝聚蛋白突变、城市环境及多敏化/过敏共病与持续AD和特应性共病风险相关,并据此提供识别高危患儿、咨询与转诊的临床指南及临床情景。

要点

  • 早发、家族特应性史、AD严重、丝聚蛋白突变、城市环境及多敏化/过敏共病提示AD进展风险较高。
  • 临床可依据上述因素识别可能持续AD或发生特应性共病的高危患儿。
  • 对高危患儿应加强监测,必要时转诊专科。

核心结论

  • 儿童AD存在不同疾病轨迹,部分患儿将持续AD或发生特应性共病。
  • 早发、家族特应性史、AD严重度、丝聚蛋白突变、城市环境及多敏化/过敏共病与AD进展风险相关。

研究设计与样本

  • 综述近期队列研究,综合并简化流行病学数据,识别有助于估计儿童AD进展风险的临床特征。

主要发现

  • 尽管数据收集与分析方法存在变异和局限,早期儿童AD存在共同模式可帮助估计疾病进展风险。
  • 与AD进展风险相关的因素包括:发病年龄较小、特应性家族史、AD严重度较高、丝聚蛋白突变、城市环境以及多敏化/过敏共病。

关键数值与推荐

  • 基于上述因素提供临床医生指南,用于识别、咨询和/或转诊可能进展为持续AD和特应性共病风险较高的婴幼儿和儿童。
  • 提供临床情景以说明数据如何与真实情况关联。

临床怎么用

  • 临床医生可依据发病年龄、家族史、AD严重度、丝聚蛋白突变、环境及敏化/共病因素评估患儿AD进展风险。
  • 对高危患儿加强监测,必要时转诊专科。

局限性

  • 数据收集与分析方法存在变异,且研究存在局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Atopic dermatitis (AD) is a heterogeneous disease with a multifactorial aetiology and complex pathophysiology. This heterogeneity translates into different trajectories of disease progression with respect to severity, persistence and risk of development of atopic comorbidities. Determining which possible disease trajectories or comorbidities any individual child might develop is challenging in clinical practice. Tools that help identify paediatric patients at higher risk of disease progression would greatly aid clinicians. METHODS: We reviewed recent cohort studies to synthesize and simplify the epidemiological data to try to identify shared clinically relevant characteristics that may help physicians estimate the risk of disease progression in paediatric patients with AD. RESULTS: Despite the variability in data collection and methods of analysis and their limitations, there are common patterns of early-childhood AD that may aid in the estimation of risk for disease progression. Factors associated with risk of AD progression include younger age of onset, family history of atopy, greater AD severity, filaggrin mutations, urban environment and polysensitization and/or allergic multimorbidity. Based on these factors, we provide a practitioner's guide for identifying, counselling and/or referring infants and children with AD at potentially higher risk of developing persistent AD and atopic comorbidities. We also present clinical scenarios to illustrate how these data relate to real-life situations. CONCLUSIONS: Useful insights are provided for physicians and patients to inform them better about the risk of AD progression and to help guide care pathways for the paediatric population with AD. What's already known about this topic? The complex pathophysiology of atopic dermatitis (AD) translates into a heterogeneous clinical presentation and trajectories of disease progression. Although the consensus is that most paediatric patients with AD will eventually 'outgrow' the disease or follow the longitudinal trajectory known as the 'atopic march', a significant proportion will develop persistent AD and/or other atopic conditions. No known factors conclusively predict the risk of progression or development of comorbidities. What does this study add? Recent analyses of data from large cohorts of paediatric patients with AD have suggested the existence of potentially discrete clusters of patients who present with relatively common AD phenotypes. These studies have shed some light onto the factors associated with risk of progression, which we review in this article. A practitioner's guide with clinical scenarios is provided to help identify patients at high risk of progression to determine whether a patient should be monitored and/or would require specialist referral.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Irvine AD, Mina-Osorio P. Disease trajectories in childhood atopic dermatitis: an update and practitioner's guide. Br J Dermatol. 2019. PMID: 30758843. doi:10.1111/bjd.17766

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。